Skip to content
OpenCapital
Get started

Aurinia Pharmaceuticals AUPH Operating Lease ROU Assets

Operating Lease ROU Assets at other companies

Rogers Corporation logo
Rogers CorporationROG
$18.5M-20.9%
Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO
5.7%0.0pp
Kiniksa Pharmaceuticals International, plc logo
Kiniksa Pharmaceuticals International, plcKNSA
$9.33M-10.7%
Alumis Inc. logo
Alumis Inc.ALMS
$15.95M+12.1%
Apogee Therapeutics, Inc. logo
Apogee Therapeutics, Inc.APGE
$7.71M-33.0%
LQD
Liquidia CorporationLQDA
$4.36M+5.5%

Segments

By geography

See full
Visp, Switzerland$69.5M-20.0%

Other financials

Income statement

See full
Revenue$77.7M+24.4%
Gross profit$71.2M+32.1%
Operating income$41.4M+89.6%
Net income$34.4M+47.2%
EPS (diluted)$0.25+56.3%

Balance sheet

See full
Cash & equivalents$41.0M-38.3%
Total debt$85.2M-7.9%
Total equity$567.6M+62.1%
Total assets$724.0M+43.4%

Cash flow

See full
Operating cash flow$32.6M+2,405%

Valuation

See full
Market cap$2.39B+78.5%

Profitability

See full
Gross margin89.7%+1.5pp
Operating margin41.7%+29.4pp
Net margin100%+83.9pp

Returns & leverage

See full
Return on equity65%+53.8pp
Debt / equity0.2×-0.1×
Current ratio5.5×-0.4×

Where this comes from

Reported directly by Aurinia Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Aurinia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aurinia Pharmaceuticals's operating lease rou assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Aurinia Pharmaceuticals's operating lease ROU assets?
Aurinia Pharmaceuticals (AUPH) reported operating lease ROU assets of $1.66M in Q1 2026.
How has Aurinia Pharmaceuticals's operating lease ROU assets changed year-over-year?
Aurinia Pharmaceuticals's operating lease ROU assets decreased by 58.0% year-over-year, from $3.95M to $1.66M.
What is the long-term trend for Aurinia Pharmaceuticals's operating lease ROU assets?
Over 5 years (2020 to 2025), Aurinia Pharmaceuticals's operating lease ROU assets has grown at a -8.1% compound annual growth rate (CAGR), from $5.49M to $3.6M.
What does operating lease ROU assets mean?
Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.